|
|
| Catalent Appoints Julien Meissonnier as Vice President and Chief Scientific Officer | |
|
|
|
| Catalent recently announced the appointment of Julien Meissonnier to Vice President and Chief Scientific Officer and is now part of Catalent’s executive leadership team. Driving growth and innovation he heads up the company’s scientific community and customer advisory partnerships helping to improve formulation and adoption of new drug delivery technologies. He is also co-chair for the Catalent Applied Drug Delivery Institute, that leverages emerging new therapeutic modalities. |
|
| |
|
| | |
Julien is instrumental in driving the Scientific advisory team that helps customers choose the right formulation and final dose form technology for their product. Before his most recent appointment, Mr. Meissonnier previously held the position of Vice President, Science and Technology, and before that led Catalent’s European softgel R&D team. He holds an engineering degree in physico-chemistry from the ENSI in Caen, France.
|
|
---|
| |
|
|
|
|
|
|
| Buttressing Catalent expertise in accelerated and orphan launches, especially in oncology Catalent has made some recent news in the immune oncology drug market. |
|
| |
|
|
|
|
|
|
| Catalent has entered into a long-term commercial supply agreement with BeiGene, Ltd., a biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. |
|
| |
|
|
|
|
|
|
| Catalent recently appointed Mike Grippo as Senior Vice President, Strategy and Corporate Development. In this newly created role, Mr. Grippo will be responsible for identifying and evaluating organic and inorganic growth opportunities across Catalent that will drive long-term shareholder value. Alongside his appointment, Julien Meissonnier has been named as Vice President and Chief Scientific Officer, and will report to Mr. Grippo. |
|
| |
|
|
|
|
|
|
| John Chiminski, Catalents Chair and CEO, has received the inaugural CPhI Pharma Awards ‘Lifetime Achievement Award’ at the world’s largest pharmaceutical exhibition, CPhI Worldwide, at Messe Frankfurt, Germany on November 5. |
|
| |
|
|
| A Catalyst in Drug Development | |
|
|
|
| Todd Stone, Ph.D. Senior Manager – Analytical & Formulation Development |
|
| |
|
|
| | | Todd Stone, Ph.D. is a Senior Manager in Analytical & Formulation Development at Catalent’s Bloomington, Indiana site. He and his team focus on developing statistically rigorous analytical methods and high throughput formulation strategies using principles of Quality by Design (QbD). His responsibilities are to lead the scientific direction of the analytical and formulation groups to ensure Catalent deploys the most modern analysis techniques and to provide clients with the highest quality data characterizing the critical quality attributes of their molecules. Discover what drives his passion for analytical work. Access his works that include 6 peer reviewed articles and scientific posters. |
|
---|
| |
|
|
|
|
| How to Effectively Work with a Development Partner – From a Consultants View |
|
| |
|
|
| | | Join us in San Diego, California for this exciting event, specifically designed for consultants. Hear from three experienced Pharmaceutical industry colleagues on the latest tips and techniques that will help your clients avoid critical pitfalls in early development of their drugs to best leverage CDMO experts to help manage and mitigate risks for your clients’ programs. Learn the latest approaches to accelerate your path to clinic and connect with our experts during the event. In addition, take a hands-on tour of Catalent’s San Diego facility that focuses on early development and the home of our Catalent Spray Drying Technology, followed up by further networking at Ballast Point Brewing Company. |
|
---|
| |
|
|
|
|
|
|
| | | CLINICAL SUPPLY / CLINICAL SERVICES Article: “How Protocol Design Drives Comparator Sourcing Cost, Timelines, Complexity, and Risk” - Clinical trial protocol design can have a significant impact on the sourcing strategy for commercial drug products used as comparators. This article presents was to use proper planning, effective communication with specialized experts, and providing the appropriate level of detail in the clinical trial protocol to help avoid sourcing issues and can minimize protocol amendments. Ebook: “Primary Packaging Strategies for Clinical Trials” - Planning for a clinical supply project? Having a well-thought out packaging design strategy is crucial. Download the eBook to get expert insights on the best packaging strategies to solve stability and blinding concerns, address country-specific regulatory requirements, overcome kit configuration challenges, support patient-centered design and more. Webinar: “Shortening Timelines with Clinical Trial Strategy” - Learn the advantages of integrated supply chain strategy, overcoming trial complexities, cold chain logistics, and regulatory landscape. This webinar presents essential components of clinical supply strategy. |
|
---|
| |
|
|
|
|
| | | CONSUMER HEALTH Article: “Next Generation Softgel Technology: Delivering Better Omega-3 Supplements” - One of the consumer challenges in taking Omega-3 softgels is fishy burps. Catalent has developed a patented microemulsion technology that enables better surface absorption, reducing burps without the need for coating during the manufacturing process. Case Study: “Creating the Best-Selling ‘Beauty from Within’ Softgel Product Line” – Learn how Catalent’s formulation development and manufacturing expertise helped a topical skincare company to successfully launch a brand new ingestible supplement for the global market. Webinar: “OTC Innovation to Avoid Stagnation” - Industry experts from Nicolas Hall Companies will provide a perspective on the importance of innovation in OTC, and discuss strategies for engaging consumers through the use of real-world case studies. Get expert insights on innovations and how to achieve it for your next product. |
|
---|
| |
|
|
| We are growing. We are hiring. Join us! | |
|
|
|
| | | Catalent hires people with a passion to make a difference. We are rapidly growing across all functions including Supply Chain, Manufacturing, Quality, Product Development, Human Resources & more. Apply today!
Hear what our employees have to say about working at Catalent here. |
|
---|
| |
|
|
| Upcoming Expert Presentations, Webinars and Events | |
|
|
|
| Webinar | A Novel Approach for High-Expressing CHO Cell Line Engineering | December 2, 2019 Cell Therapy & Gene Therapy Manufacturing Congress 2019 | December 4-6, 2019 |Amsterdam, The NetherlandsWebinar | Planning a Rapid Commercial Market Launch of Your Biologic | December 4, 2019 Recent Advances in New Drug Development | December 10 – 11, 2019 | Nottingham, UK Clinical Trial Supply East Asia | December 11-12, 2019 | Seoul, South Korea Drug Delivery to the Lungs 2019 | December 11 - 13, 2019 | Edinburgh, UK How to Effectively Work with a Development Partner – A Consultant Viewpoint | January 8, 2020 | San Diego, California | USA Phacilitate | January 22-25, 2020 | Miami, Florida | USA CASS WCBP | January 28-30, 2020 | Washington, D.C. | USA |
|
| |
|
|
| Every brand has a challenge. We have a solution. |
| | | | or call +1 877 891 9609 to speak with one of our experts today! |
| |
|
| To unsubscribe or manage your subscriptions, please click here. For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers. Catalent Pharma Solutions respects your privacy. Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement or the website, its owner(s) or the content. | © 2019, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|